Compound ID | 2140
Class: Small molecule antibacterial agent
Spectrum of activity: | Gram-positive |
Details of activity: | Binds to type II topoisomerases, gyrase and topoisomerase IV and thus, inhibits DNA cleavage and ligation reactions. Activity against mainly Gram-positive bacteria. |
Description: | Synthetic compound; oxabicyclooctane-linked NBTI containing a pyridoxazinone and naphthyridone |
Institute where first reported: | Merck |
Year first mentioned: | 2014 |
Highest developmental phase: | Phase 1 |
Development status: | Terminated |
Chemical structure(s): | |||||||||||
|
|